Literature DB >> 21832146

Expression of ezrin in human embryonic, fetal, and normal adult tissues.

Jian-Jun Xie1, Fa-Ren Zhang, Li-Hua Tao, Zhuo Lü, Xiu-E Xu, Li-Yan Xu, En-Min Li.   

Abstract

Ezrin, which cross-links the cytoskeleton and plasma membrane, was involved in a wide variety of cellular processes. Here, to investigate the distribution of ezrin, tissue microarray technology was employed to perform immunohistochemical experiments on human embryos, fetuses at 4 to 22 weeks' gestation, and adult tissue specimens. Results showed that ezrin was widely expressed in the gastrointestinal tract throughout the human developmental stages studied. At 6 to 8 weeks' gestation, ezrin was found in epithelial cells, and this staining pattern was particularly pronounced in the brush border of mature absorptive cells lining the villus in later developmental stages and adult tissues. Throughout neural development, ezrin was only expressed in the neural tube at 4 weeks' gestation. Ezrin was also detected in the cortex and medulla of the adrenal gland at 8 to 12 weeks' gestation, whereas its immunoreactivity was increased from the zona glomerulosa through the zona reticularis and was essentially undetectable in the adrenal medulla of adult tissues. Significant expression of ezrin was seen throughout development in the kidney, spleen, lymph nodes, and cells of stratified squamous epithelia. However, ezrin was undetectable in lung, liver, heart, and blood vessels. These results demonstrated that the expression pattern of ezrin was highly time specific and tissue specific.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832146      PMCID: PMC3261628          DOI: 10.1369/0022155411418661

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  46 in total

1.  Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma.

Authors:  Rashna Madan; Margaret Brandwein-Gensler; Nicolas F Schlecht; Kristin Elias; Eleanor Gorbovitsky; Thomas J Belbin; Radma Mahmood; Dwayne Breining; Hong Qian; Geoffrey Childs; Joseph Locker; Richard Smith; Missak Haigentz; Frank Gunn-Moore; Michael B Prystowsky
Journal:  Head Neck       Date:  2006-11       Impact factor: 3.147

2.  Identification of differentially expressed genes in metastatic and non-metastatic nasopharyngeal carcinoma cells by suppression subtractive hybridization.

Authors:  Xu-Yu Yang; Cai-Ping Ren; Lei Wang; Hui Li; Chun-Jie Jiang; Hong-Bo Zhang; Ming Zhao; Kai-Tai Yao
Journal:  Cell Oncol       Date:  2005       Impact factor: 6.730

3.  The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness.

Authors:  Yan Zhang; Mei-Yu Hu; Wei-Zhong Wu; Zhi-Jun Wang; Kang Zhou; Xi-Liang Zha; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-20       Impact factor: 4.553

4.  Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.

Authors:  Jian-Jun Xie; Li-Yan Xu; Zhi-Yong Wu; Qing Zhao; Xiu-E Xu; Jian-Yi Wu; Qiao Huang; En-Min Li
Journal:  J Surg Oncol       Date:  2011-03-17       Impact factor: 3.454

5.  Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.

Authors:  Rachel A Craven; Anthea J Stanley; Sarah Hanrahan; James Dods; Richard Unwin; Nick Totty; Patricia Harnden; Ian Eardley; Peter J Selby; Rosamonde E Banks
Journal:  Proteomics       Date:  2006-05       Impact factor: 3.984

6.  Altered expression of ezrin in esophageal squamous cell carcinoma.

Authors:  Hongmei Zeng; Liyan Xu; Dawei Xiao; Haihua Zhang; Xianying Wu; Ruiming Zheng; Qiaoshan Li; Yongdong Niu; Zhongying Shen; Enmin Li
Journal:  J Histochem Cytochem       Date:  2006-04-03       Impact factor: 2.479

7.  Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.

Authors:  David Sarrió; Socorro María Rodríguez-Pinilla; Ana Dotor; Francisco Calero; David Hardisson; José Palacios
Journal:  Breast Cancer Res Treat       Date:  2006-03-15       Impact factor: 4.872

8.  Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.

Authors:  J Song; J Bai; W Yang; E W Gabrielson; D W Chan; Z Zhang
Journal:  Histopathology       Date:  2007-07       Impact factor: 5.087

9.  Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type.

Authors:  Nebil Bal; Sedat Yildirim; Tarik-Z Nursal; Filiz Bolat; Fazilet Kayaselcuk
Journal:  World J Gastroenterol       Date:  2007-07-21       Impact factor: 5.742

10.  Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases.

Authors:  Xiyun Deng; Sarah H Tannehill-Gregg; Murali V P Nadella; Guangchun He; Andrea Levine; Ya Cao; Thomas J Rosol
Journal:  Clin Exp Metastasis       Date:  2007-03-17       Impact factor: 4.510

View more
  3 in total

1.  Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.

Authors:  M Bartova; J Hlavaty; Y Tan; C Singer; K Pohlodek; J Luha; I Walter
Journal:  Clin Exp Metastasis       Date:  2017-06-17       Impact factor: 5.150

2.  ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.

Authors:  Jian-Jun Xie; Yang-Min Xie; Bo Chen; Feng Pan; Jin-Cheng Guo; Qing Zhao; Jin-Hui Shen; Zhi-Yong Wu; Jian-Yi Wu; Li-Yan Xu; En-Min Li
Journal:  Oncotarget       Date:  2014-09-30

3.  Immunohistochemical Expression Of Ezrin In Oral Potentially Malignant Disorders-A Descriptive Study.

Authors:  Raghini Mohanraj; Pratibha Ramani; Priya Premkumar; Anuja Natesan; Herald J Sherlin; Gheena Sukumaran
Journal:  J Pharm Bioallied Sci       Date:  2017-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.